# Phio Pharmaceuticals Corp.: Form 8-K, filed Jan 5, 2018

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2018-01-05
- Accepted by EDGAR: Jan 5, 2018, 17:21 ET
- Period: 2018-01-04
- Accession: 0001193125-18-004623
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000119312518004623/d521436d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000119312518004623/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000119312518004623/d521436d8k.htm

Filed Jan 5, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-004623. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
